# Contact Online PT-141: Editorial Questions and Corrections

> Contact Online PT-141, an independent editorial digest of the PT-141 (bremelanotide) research literature. For editorial questions and corrections only — no medical advice, no sales.

Questions about the literature, or a correction to flag? We'd like to hear it.

## Get in touch

Online PT-141 is an editorial digest of the PT-141 (bremelanotide) research literature, and this form is for editorial matters only — questions about a study we cite, suggestions for sources we've missed, or corrections to anything on the site. We read every message, and we take accuracy seriously: if we've gotten a citation or a number wrong, tell us and we'll fix it.

Use the form below to reach the editorial team. A short, specific note works best — if you're pointing to a study, a title or a PMID/DOI helps us find it fast.

## What we can't help with

A few things we genuinely cannot do, so we don't waste your time. We can't give medical advice, recommend a dose, or tell you whether PT-141 is right for you or anyone else — those are questions for a qualified clinician who knows the full picture. We don't diagnose, we don't treat, and we don't run a clinic.

We also don't sell, supply, source, or ship PT-141 or any other compound, and we can't point you to a vendor — this is a research digest, not a store. Anything about buying, pricing, or obtaining the compound is outside what we do. For the science itself, the [research](/research), [side effects](/side-effects), and [references](/references) pages are the best place to start.

---

A bright, plain-English digest of the PT-141 (bremelanotide) record — the one approved use, the modest benefit, and the nausea-led tolerability cost read first and cited to source, with the community field reports kept squishily to one side and clearly marked unverified; a friendly reading desk, not a clinic, and nothing here dosed, sourced, or sold.